Fabino Lifesciences Ltd. is a growing pharmaceutical company located near the Delhi NCR region of India. We are a perfect blend of knowledge, competency, experience, and passion which has enabled us to offer you a wide range of allopathic and herbal products. We understand your healthcare requirements and offer top-quality products to meet your specific needs.
Their company emphasizes developing high-quality and affordable products for all sections of society by harnessing the skills of our competent manpower, resources, and state of art infrastructural facilities. We understand your health and will not leave any stone unturned to accomplish our goal of providing the best quality products at affordable rates for good health and well-being for all.
Atul Kumar Jain is the company promoter.
Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
---|---|---|---|
Total Assets (In ₹ Millions) | 22.51 | 35.88 | 85.53 |
Total Revenue (In ₹ Millions) | 30.59 | 75.16 | 27.61 |
Profit After Tax (PAT) (In ₹ Millions) | 0.30 | 0.68 | 0.001 |
Date | GMP | Kostak | Subject to Sauda |
---|
Date & Time | QIB | NII | RII | Total |
---|---|---|---|---|
Day 1 - 31 Dec 2021 | ||||
Day 2 - 03 Jan 2022 | ||||
Day 3 - 04 Jan 2022 | ||||
Day 3 - 05 Jan 2022 |
Please click the link below to check the IPO allotment status.
IPO Allotment StatusFabino Life Sciences Limited IPO will open on 31 Dec 2021 and close on 5 Jan 2022.
Fabino Life Sciences Limited IPO will list on 13 Jan 2022.
The offer price of Fabino Life Sciences Limited IPO is ₹36.
The lot size of Fabino Life Sciences Limited IPO is 3000.
The Grey Market Premium (GMP) price of Fabino Life Sciences Limited IPO is Not Available at the moment.
The Kostak price of Fabino Life Sciences Limited IPO is Not Available at the moment.
The Subject to Sauda price for Fabino Life Sciences Limited IPO is Not Available at the moment.
Please Leave Your Message
Fabino Life Sciences Limited IPO Review/Comments